In the present study, clinical features and information on TPH2 methylation were gathered to establish prediction models for the early-stage antidepressant response in the Chinese Han population, leading to the identification of important CpGs as potential biomarkers in the early MDD treatment. Here, TPH2 is linked to major depressive disorder.